MétaCan
Menu
Back to cohort
Record W4403986853 · doi:10.1001/jamaneurol.2024.3770

Alzheimer Disease as a Clinical-Biological Construct—An International Working Group Recommendation

2024· letter· en· W4403986853 on OpenAlexfundno aff
Bruno Dubois, Nicolas Villain, Lon S. Schneider, Nick C. Fox, Noll L. Campbell, Douglas Galasko, Miia Kivipelto, Frank Jessen, Bernard Hanseeuw, Merçé Boada, Frederik Barkhof, Agneta Nordberg, Lutz Froelich, Gunhild Waldemar, Kristian Steen Frederiksen, Alessandro Padovani, Vincent Planche, Christopher C. Rowe, Alexandre Bejanin, Agustín Ibáñez, Stefano F. Cappa, Paulo Caramelli, Ricardo Nitríni, Ricardo Allegri, Andrea Slachevsky, Leonardo Cruz de Souza, Andrea Bozoki, Eric Widera, Kaj Blennow, Craig Ritchie, Marc Agronin, Lisa Delano‐Wood, Stéphanie Bombois, Richard Lévy, Madhav Thambisetty, Jean Georges, David T. Jones, Helen Lavretsky, Jonathan M. Schott, Jennifer R. Gatchel, Sandra Swantek, Paul Newhouse, Howard Feldman, Giovanni B. Frisoni

Bibliographic record

VenueJAMA Neurology · 2024
Typeletter
Languageen
FieldMedicine
TopicDementia and Cognitive Impairment Research
Canadian institutionsnot available
FundersCilagJane and Terry Semel Institute for Neuroscience and Human Behavior, University of California, Los AngelesNational Institute on AgingSahlgrenska AkademinInstituto de Salud Carlos IIIGeriatric Research Education and Clinical CenterFondo de Financiamiento de Centros de Investigación en Áreas PrioritariasUniversity of North Carolina at Chapel HillFogarty International CenterNational Institutes of HealthUniversity College LondonGrifolsClínica Alemana de SantiagoSiemens HealthineersServierUniversitat Autònoma de BarcelonaMassachusetts General HospitalUniversidade Federal de Minas GeraisUniversidad de ChileNIH Clinical CenterFleniAssociation de soutien à la Paralysie Supranucléaire ProgressiveGöteborgs UniversitetSahlgrenska UniversitetssjukhusetUniversidade de São PauloEli Lilly and CompanyUniversity of St AndrewsFundação de Amparo à Pesquisa do Estado de Minas GeraisSanofiUniversidad de AntioquiaNovo NordiskEisaiFonds De La Recherche Scientifique - FNRSConselho Nacional de Desenvolvimento Científico e TecnológicoAlzheimer's AssociationGlobal Brain Health InstituteAgencia Nacional de Investigación y DesarrolloUniversité de GenèveTrinity College DublinCerveau TechnologiesVeterans Affairs San Diego Healthcare SystemUniversity of California, Los AngelesProthenaJulius ClinicalVanderbilt University Medical CenterFondation pour la Recherche sur AlzheimerEuropean CommissionMcLean HospitalVanderbilt UniversityBiogenTauRx PharmaceuticalsUniversity of California, San FranciscoAlzheimer SocietyBristol-Myers SquibbUniversity of California, San DiegoU.S. Department of Veterans Affairs
KeywordsConstruct (python library)DiseaseAlzheimer's diseaseGroup (periodic table)MedicinePsychologyNeuroscienceInternal medicineComputer science

Abstract

fetched live from OpenAlex

Importance: Since 2018, a movement has emerged to define Alzheimer disease (AD) as a purely biological entity based on biomarker findings. The recent revision of the Alzheimer's Association (AA) criteria for AD furthers this direction. However, concerns about a purely biological definition of AD being applied clinically, the understanding of AD by society at large, and the translation of blood-based biomarkers into clinical practice prompt these International Working Group (IWG) updated recommendations. Objective: To consider the revised AA criteria and to offer an alternative definitional view of AD as a clinical-biological construct for clinical use. The recommendations of the 2021 IWG diagnostic criteria are updated for further elaborating at-risk and presymptomatic states. Evidence Review: PubMed was searched for articles published between July 1, 2020, and March 1, 2024, using the terms "biomarker" OR "amyloid" OR "tau" OR "neurodegeneration" OR "preclinical" OR "CSF" OR "PET" OR "plasma" AND "Alzheimer's disease." The references of relevant articles were also searched. Findings: In the new AA diagnostic criteria, AD can be defined clinically as encompassing cognitively normal people having a core 1 AD biomarker. However, recent literature shows that the majority of biomarker-positive cognitively normal individuals will not become symptomatic along a proximate timeline. In the clinical setting, disclosing a diagnosis of AD to cognitively normal people with only core 1 AD biomarkers represents the most problematic implication of a purely biological definition of the disease. Conclusions and Relevance: The ultimate aim of the field was to foster effective AD treatments, including preventing symptoms and dementia. The approach of diagnosing AD without a clinical and biological construct would be unwarranted and potentially concerning without a clear knowledge of when or whether symptoms will ever develop. It is recommended that those who are amyloid-positive only and, more generally, most biomarker-positive cognitively normal individuals, should not be labeled as having AD. Rather, they should be considered as being at risk for AD. The expansion of presymptomatic AD is viewed as a better diagnostic construct for those with a specific pattern of biomarkers, indicating that they are proximate to the expression of symptoms in the near future.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.071
metaresearch head score (Gemma)0.171
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Theoretical or conceptual · Consensus signal: none
GenreCandidate signal: Commentary · Consensus signal: Commentary
Teacher disagreement score0.071
Threshold uncertainty score0.374

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0710.171
Meta-epidemiology (narrow)0.0030.002
Meta-epidemiology (broad)0.0080.015
Bibliometrics0.0150.015
Science and technology studies0.0020.003
Scholarly communication0.0090.013
Open science0.0120.009
Research integrity0.0170.015
Insufficient payload (model declined to judge)0.0160.014

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.106
GPT teacher head0.411
Teacher spread0.304 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designTheoretical or conceptual
Domainnot available
GenreCommentary

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations352
Published2024
Admission routes1
Has abstractyes

Explore more

Same venueJAMA NeurologySame topicDementia and Cognitive Impairment ResearchFrench-language works237,207